Shaw Neural Dynamics Corporation

Shaw Neural Dynamics (SND) is a Vancouver based biotechnology company dedicated to the prevention of cytoskeletal disorders which include Alzheimers (AD), Parkinson’s (PD) and Lou Gehrig’s disease (ALS).

SND has identified an important molecule, a sterol glucoside, which plays a pivotal role in the development of cytoskeletal disorders.

Activity:

- Clinical Trials
- Informatics
- Licensing & Business Development
- Manufacturing
- Research & Development
- Sales & Distribution

Product / Technology type(s) covered:

- Bio
- Curative
- Diagnostics
- Generics
- Pharmaceuticals / Therapeutics
- Preventive
- Reagents
- Technology

Therapeutic targets:

- Aging
- Alzheimer's Disease
- Central nervous system
- Genetics
- Infectious Diseases
- Neurology
- Obesity
- Ophthalmology

Markets Covered

a. HeadQuarter: Canada

b. Continent(s) active: North America , Europe , Australia/New-Zealand , Central/South America , Asia , Far East , Near/Middle East , Africa

c. Countries active: U.S.A., Canada, United Kingdom, France, Germany, Netherlands, Italy, Spain, Portugal, Australia, China, Japan, Mexico, Brazil, Argentina

Corporate data:

Number of Employees: 20

Turnover:

Amount:	Year:	Currency:
Private	2002	US Dollar

Year founded: 2001

Partners / Alliances: Shaw Neural Dynamics Corporation is a subsidiary of Dynamikos Corporation. Group Corporate affiliations include: Ufford Sahib Terminals Corporation; UST Export Corporation; Mildrush Designs Corporation; and Sovereign Security Corporation.